Zacks Research Downgrades Intuitive Surgical (NASDAQ:ISRG) to Hold

Intuitive Surgical (NASDAQ:ISRG) was downgraded by investment analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued on Monday,Zacks.com reports.

Other analysts have also recently issued research reports about the company. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price for the company in a research report on Wednesday, March 11th. Barclays set a $712.00 price target on Intuitive Surgical and gave the stock an “overweight” rating in a report on Monday, January 26th. UBS Group cut their price objective on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. Finally, Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $614.95.

Intuitive Surgical Stock Performance

ISRG opened at $460.99 on Monday. The stock has a market cap of $163.71 billion, a price-to-earnings ratio of 58.43, a price-to-earnings-growth ratio of 3.49 and a beta of 1.66. The firm’s fifty day moving average is $491.53 and its 200 day moving average is $513.74. Intuitive Surgical has a fifty-two week low of $425.00 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.21 EPS. On average, equities research analysts predict that Intuitive Surgical will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president owned 409 shares in the company, valued at $202,438.64. This trade represents a 50.72% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the sale, the vice president directly owned 660 shares in the company, valued at approximately $326,673.60. The trade was a 16.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 32,943 shares of company stock valued at $17,279,568 in the last 90 days. 0.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. SteelPeak Wealth LLC boosted its position in Intuitive Surgical by 28.7% during the 3rd quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after acquiring an additional 9,364 shares in the last quarter. Atlantic Union Bankshares Corp raised its position in shares of Intuitive Surgical by 19.3% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock worth $10,179,000 after acquiring an additional 3,676 shares in the last quarter. World Investment Advisors raised its position in shares of Intuitive Surgical by 238.3% in the 3rd quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock worth $2,415,000 after acquiring an additional 3,803 shares in the last quarter. E. Ohman J or Asset Management AB lifted its stake in shares of Intuitive Surgical by 4.1% during the 3rd quarter. E. Ohman J or Asset Management AB now owns 28,306 shares of the medical equipment provider’s stock worth $12,659,000 after purchasing an additional 1,123 shares during the last quarter. Finally, Valley Wealth Managers Inc. lifted its stake in shares of Intuitive Surgical by 52.7% during the 3rd quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock worth $1,826,000 after purchasing an additional 1,409 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst/technical optimism: Commentary noting ISRG is technically oversold and that Wall Street estimate revisions are tilting upward is supporting a near-term bounce and buy-the-dip demand. Down 10.1% in 4 Weeks, Here’s Why Intuitive Surgical (ISRG) Looks Ripe for a Turnaround
• Positive Sentiment: Fundamentals remain supportive: Intuitive posted an EPS and revenue beat in its latest quarter with healthy margins and double‑digit revenue growth year-over-year — this gives investors confidence that demand for robot-assisted procedures and consumables can reaccelerate. (See company reports and recent earnings commentary.)
• Neutral Sentiment: Market recap: Recent news pieces note ISRG rose but still lagged the broader market on the session, reflecting mixed investor appetite versus larger-cap growth peers. Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know
• Neutral Sentiment: Sector/peer headlines may influence sentiment: Big moves in med‑tech peers (large drawdowns at some names and product launches at others) are creating rotation and headline-driven volatility that can impact ISRG. Examples include coverage of Boston Scientific’s selloff and Baxter’s new IV labeling system. Can Boston Scientific Stock Surge 40% From Here? Baxter International Unveils IV Verify to Enhance IV Labeling Accuracy
• Negative Sentiment: Technical and momentum concerns remain: ISRG has been through a recent pullback (50‑day moving average below the 200‑day) and a multi-week decline that could keep downside risk elevated if procedure volumes or guidance disappoint. Investors should watch upcoming volumes, guidance, and margin commentary closely.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.